These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24660626)

  • 21. Effective inhibition in animals of viral pathogenesis by a ribozyme derived from RNase P catalytic RNA.
    Bai Y; Trang P; Li H; Kim K; Zhou T; Liu F
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10919-24. PubMed ID: 18663226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the regions of RNase P catalytic RNA that are potentially in close contact with its protein cofactor.
    Trang P; Liu F
    Methods Mol Biol; 2008; 488():267-77. PubMed ID: 18982298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. General design and construction of RNase P ribozymes for gene-targeting applications.
    Zou H; Chan K; Trang P; Liu F
    Methods Mol Biol; 2004; 252():385-98. PubMed ID: 15017065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNase P ribozymes for the studies and treatment of human cytomegalovirus infections.
    Trang P; Kilani A; Lee J; Hsu A; Liou K; Kim J; Nassi A; Kim K; Liu F
    J Clin Virol; 2002 Aug; 25 Suppl 2():S63-74. PubMed ID: 12361758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNase P ribozyme inhibits cytomegalovirus replication by blocking the expression of viral capsid proteins.
    Kim K; Trang P; Umamoto S; Hai R; Liu F
    Nucleic Acids Res; 2004; 32(11):3427-34. PubMed ID: 15220469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective inhibition of human immunodeficiency virus 1 replication by engineered RNase P ribozyme.
    Zeng W; Chen YC; Bai Y; Trang P; Vu GP; Lu S; Wu J; Liu F
    PLoS One; 2012; 7(12):e51855. PubMed ID: 23300569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNase P ribozyme as an antiviral agent against human cytomegalovirus.
    Trang P; Liu F
    Methods Mol Biol; 2004; 252():437-50. PubMed ID: 15017069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced antiviral effect in cell culture of type 1 interferon and ribozymes targeting HCV RNA.
    Macejak DG; Jensen KL; Pavco PA; Phipps KM; Heinz BA; Colacino JM; Blatt LM
    J Viral Hepat; 2001 Nov; 8(6):400-5. PubMed ID: 11703570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme.
    Trang P; Lee J; Kilani AF; Kim J; Liu F
    Nucleic Acids Res; 2001 Dec; 29(24):5071-8. PubMed ID: 11812839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Construction of HCV-producing cell model based on self-cleaving ribozyme].
    Wang S; An XP; Mi ZQ; Liu DB; Zhang BZ; Lv J; Zhou YS; Tong YG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jun; 18(6):437-9. PubMed ID: 20587314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered RNase P Ribozymes Effectively Inhibit the Infection of Murine Cytomegalovirus in Animals.
    Li W; Liu Y; Wang Y; Li R; Trang P; Tang W; Yang Z; Wang Y; Sun X; Xing X; Lu S; Liu F
    Theranostics; 2018; 8(20):5634-5644. PubMed ID: 30555569
    [No Abstract]   [Full Text] [Related]  

  • 32. Ribozyme-Mediated Downregulation Uncovers DNA Integrity Scanning Protein A (DisA) as a Solventogenesis Determinant in
    Ujor VC; Lai LB; Okonkwo CC; Gopalan V; Ezeji TC
    Front Bioeng Biotechnol; 2021; 9():669462. PubMed ID: 34169065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on the cleavage activity of U1 small nuclear RNA chimeric ribozyme against HCV RNA in vitro].
    Tian MM; Wang F; Niu JQ; Wang MX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):749-51. PubMed ID: 15619345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ribozyme-mediated selective induction of new gene activity in hepatitis C virus internal ribosome entry site-expressing cells by targeted trans-splicing.
    Ryu KJ; Kim JH; Lee SW
    Mol Ther; 2003 Mar; 7(3):386-95. PubMed ID: 12668134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Construction of a full-genome HCV replicon with self-cleaving double ribozyme sequences and characterization in vitro and in vivo].
    He CL; Liu QS; Guo Y; Zhu Y; Mao Q; Lan L
    Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):348-53. PubMed ID: 24025135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclease footprint analyses of the interactions between RNase P ribozyme and a model mRNA substrate.
    Trang P; Hsu AW; Liu F
    Nucleic Acids Res; 1999 Dec; 27(23):4590-7. PubMed ID: 10556315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro Amplification and Selection of Engineered RNase P Ribozyme for Gene Targeting Applications.
    Trang P; Zhang I; Liu F
    Methods Mol Biol; 2024; 2822():419-429. PubMed ID: 38907932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cleavage of viral RNA and inhibition of viral translation by hepatitis C virus RNA-specific hammerhead ribozyme in vitro.
    Ohkawa K; Yuki N; Kanazawa Y; Ueda K; Mita E; Sasaki Y; Kasahara A; Hayashi N
    J Hepatol; 1997 Jul; 27(1):78-84. PubMed ID: 9252077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of hepatitis C virus (HCV)-RNA-dependent translation and replication of a chimeric HCV poliovirus using synthetic stabilized ribozymes.
    Macejak DG; Jensen KL; Jamison SF; Domenico K; Roberts EC; Chaudhary N; von Carlowitz I; Bellon L; Tong MJ; Conrad A; Pavco PA; Blatt LM
    Hepatology; 2000 Mar; 31(3):769-76. PubMed ID: 10706571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
    Jarczak D; Korf M; Beger C; Manns MP; Krüger M
    FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.